Long-term prognosis after coronary artery calcification testing in asymptomatic patients: A cohort study

Annals of Internal Medicine

Volumn 163, Issue 1, 2015, Pages 14-21

  Shaw, Leslee J ^a   Giambrone, Ashley E ^b   Blaha, Michael J ^c   Knapper, Joseph T ^a   Berman, Daniel S ^d   Bellam, Naveen ^e   Quyyumi, Arshed ^a   Budoff, Matthew J ^f   Callister, Tracy Q ^g   Min, James K ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^g Tennessee Heart and Vascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; VERY ELDERLY; MORTALITY; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; CAUSE OF DEATH; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84937033542     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-0612     Document Type: Article

References (35)

1. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:e584-636. [PMID: 21098428] doi:10.1161/CIR.0b013e3182051b4c
2. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610-6. [PMID: 20424251] doi:10.1001/jama.2010.461
3. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826-33. [PMID: 12869688]
4. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol. 2002;39:225-30. [PMID: 11788211]
5. Bellasi A, Lacey C, Taylor AJ, Raggi P, Wilson PW, Budoff MJ, et al. Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta-and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am J Cardiol. 2007;100:409-14. [PMID: 17659919]
6. Nasir K, Shaw LJ, Liu ST, Weinstein SR, Mosler TR, Flores PR, et al. Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol. 2007;50:953-60. [PMID: 17765122]
7. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol. 2008;52:17-23. [PMID: 18582630] doi:10.1016/j.jacc.2008.04.004
8. Oudkerk M, Stillman AE, Halliburton SS, Kalender WA, Möhlenkamp S, McCollough CH, et al; European Society of Cardiac Radiology. Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol. 2008;18:2785-807. [PMID: 18651153] doi:10.1007/s00330-008-1095-6
9. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43:1663-9. [PMID: 15120828]
10. Shaw LJ, Raggi P, Callister TQ, Berman DS. Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J. 2006;27:968-75. [PMID: 16443606]
11. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49:1860-70. [PMID: 17481445]
12. Mao SS, Pal RS, McKay CR, Gao YG, Gopal A, Ahmadi N, et al. Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner. J Comput Assist Tomogr. 2009;33:175-8. [PMID: 19346841] doi:10.1097/RCT.0b013e31817579ee
13. Schmermund A, Erbel R, Silber S; MUNICH Registry Study Group. Multislice Normal Incidence of Coronary Health. Age and gender distribution of coronary artery calcium measured by fourslice computed tomography in 2,030 persons with no symptoms of coronary artery disease. Am J Cardiol. 2002;90:168-73. [PMID: 12106852]
14. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-32. [PMID: 2407762]
15. Social Security Administration. Actuarial Life Table. Accessed at www.ssa.gov/OACT/STATS/table4c6.html on 13 April 2015.
16. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27: 157-72. [PMID: 17569110]
17. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21. [PMID: 21204120] doi:10.1002/sim.4085
18. Bérard E, Bongard V, Dallongeville J, Arveiler D, Cottel D, Wagner A, et al. 14-Year risk of all-cause mortality according to hypoglycaemic drug exposure in a general population. PLoS One. 2014;9: e95671. [PMID: 24752580] doi:10.1371/journal.pone.0095671
19. Menotti A, Mulder I, Nissinen A, Feskens E, Giampaoli S, Tervahauta M, et al. Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations; the FINE study. Finland, Italy, Netherlands, Elderly. Eur Heart J. 2001;22:573-9. [PMID: 11259144]
20. Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med. 2014;10:355-62. [PMID: 24733978] doi:10 .5664/jcsm.3600
21. Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al; China Kadoorie Biobank (CKB) collaborative group. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40:1652-66. [PMID: 22158673] doi:10.1093/ije/dyr120
22. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336-45. [PMID: 18367736] doi:10.1056/NEJMoa072100
23. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366: 321-9. [PMID: 22276822] doi:10.1056/NEJMoa1012848
24. Steele RJ, Brewster DH. Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? No. BMJ. 2011;343:d6397. [PMID: 21998348] doi:10.1136/bmj.d6397
25. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94:167-73. [PMID: 11830606]
26. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999; 34:618-20. [PMID: 10483939]
27. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308:788-95. [PMID: 22910756] doi:10.1001/jama.2012.9624
28. Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O'Malley PG. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46:807-14. [PMID: 16139129]
29. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000;36:1253-60. [PMID: 11028480]
30. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol. 2005;46:158-65. [PMID: 15992651]
31. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al; Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J AmColl Cardiol. 2010;56:1397-406. [PMID: 20946997] doi:10.1016/j.jacc.2010.06.030
32. Rozanski A, Gransar H, Wong ND, Shaw LJ, Miranda-Peats R, Polk D, et al. Clinical outcomes after both coronary calcium scanning and exercise myocardial perfusion scintigraphy. J Am Coll Cardiol. 2007;49:1352-61. [PMID: 17394969]
33. Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation. 2008;117:1693-700. [PMID: 18362235] doi:10.1161/CIRCULATIONAHA.107.717512
34. Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011;57:1622-32. [PMID: 21439754] doi:10.1016/j.jacc.2011.01.019
35. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169:2078-86. [PMID: 20008690] doi: 10.1001/archinternmed.2009.427